No Data
No Data
"Strong rivals" are coming one after the other. Eli Lilly and Co (LLY.US) has evaporated over 120 billion US dollars in market cap. Has the "Novartis duo" finally been broken?
Due to at least two competitors making encouraging progress in the treatment of obesity, Eli Lilly and Co.'s position as the leader in the weight-loss drug boom is being threatened, with market cap evaporating more than $120 billion in the past eight days.
Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Will it break the duopoly monopoly? The "new star" of weight loss drug Viking's stock price has doubled 2.4 times this year.
Eli Lilly and Co's market cap evaporated by 120 billion US dollars.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Top 20 U.S. stock trading volume on July 25th: Ford dropped sharply by 18.4%, averaging a loss of 0.3 million per electric vehicle.
On Thursday, Nvidia, the top trading company in the US, fell by 1.72%, marking its third consecutive day of decline with a turnover of 51.53 billion US dollars. Nvidia's partner SMC is reportedly raising 0.95 billion US dollars to stimulate business development with the help of AI server trends. Tesla, ranked second, rose 1.97% with a turnover of 22.201 billion US dollars. UBS Group believes that the profit return of Tesla's AI project is still far away, but the market has given it overly high expectations for its development potential, leading to its stock price far above its reasonable valuation. The bank reaffirmed its "sell" rating on Tesla. Tesla CEO Musk said on Tuesday that Tesla's value lies mainly in its autonomous driving.
Eli Lilly and Co Options Spot-On: On July 25th, 78,171 Contracts Were Traded, With 294.01K Open Interest
No Data
151841932 : don't quit
Bruce Patton OP : thank you I'm trying
Juz give me my money : don't give up, good things are yet to come
snowy wing 94 : Etfs are for long term holding. Things will look up in the long run